Stereotaxis to Present at Cowen 43rd Annual Health Care Conference

Rhea-AI Summary

ST. LOUIS, Feb. 21, 2023 – Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, announced that Chairman and CEO David Fischel will speak at the Cowen 43rd Annual Health Care Conference. The presentation is scheduled for March 6, 2023, at 11:10 am ET, during a Fireside Discussion with Cowen's Managing Director, Josh Jennings. Fischel will also hold one-on-one meetings afterwards.

Fischel expressed enthusiasm about sharing Stereotaxis’ innovative technology and growth strategy with investors, highlighting its commitment to enhancing patient care and operational efficiency.

ST. LOUIS, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Cowen 43^rd Annual Health Care Conference.

Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion with Josh Jennings, Cowen’s Managing Director & Senior Research Analyst, on Monday, March 6, 2023, at 11:10 am ET. Mr. Fischel will be available for one-on-one meetings the remainder of the day.

“We look forward to joining Cowen and sharing Stereotaxis’ differentiated technology, clinical value, and growth strategy with investors,” says Mr. Fischel.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Kimberly Peery
Chief Financial Officer

314-678-6100
Investors@Stereotaxis.com

FAQ

What is the date and time of Stereotaxis's presentation at the Cowen Health Care Conference?

Stereotaxis's presentation will take place on March 6, 2023, at 11:10 am ET.

Who is presenting at the Cowen 43rd Annual Health Care Conference for Stereotaxis?

David Fischel, Chairman and CEO of Stereotaxis, will be presenting.

What topics will be discussed by Stereotaxis at the Cowen Conference?

David Fischel will discuss Stereotaxis' business, technology, clinical value, and growth strategy.

How can investors meet with Stereotaxis representatives at the conference?

David Fischel will be available for one-on-one meetings throughout the day after the presentation.

What does Stereotaxis specialize in?

Stereotaxis specializes in surgical robotics for minimally invasive endovascular interventions.